产品库

乳腺癌易感基因环状结构域蛋白抗体

产品信息
乳腺癌易感基因环状结构域蛋白抗体,应用于IHC、WB、 IF、IP、ELISA等实验,公司生产的抗体每个流程都执行严格的检测标准,保证蛋白抗原产品质量,质量稳定,实验效果明显。按理化性质和生物学功能,可将其分为IgM、IgG、IgA、IgE、IgD五类。公司产品经无数次市场验证,若出
 产品编号Rs-4291R
英文名称BARD1
中文名称乳腺癌易感基因环状结构域蛋白抗体
别    名BARD-1; Bard1; Bard 1; BARD1_HUMAN; BRCA1 associated RING domain 1; BRCA1 associated RING domain gene 1; BRCA1 associated RING domain protein 1; BRCA1-associated RING domain protein 1.  
说 明 书0.1ml  0.2ml  
研究领域肿瘤  细胞生物  免疫学  染色质和核信号  细胞凋亡  
抗体来源Rabbit
克隆类型Polyclonal
交叉反应Human, Mouse, Rat, Chicken, Dog, Pig, Cow, Horse, 
产品应用WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500 (石蜡切片需做抗原修复) 
not yet tested in other applications.
optimal dilutions/concentrations should be determined by the end user.
分 子 量85kDa
细胞定位细胞核 
性    状Lyophilized or Liquid
浓    度1mg/1ml
免 疫 原KLH conjugated synthetic peptide derived from human BARD1
亚    型IgG
纯化方法affinity purified by Protein A
储 存 液0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
保存条件Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C.
PubMedPubMed
产品介绍background:
BRCA1 Associated RING Domain gene 1 (BARD1) interacts with the N terminal region of BRCA1. In addition to its ability to bind BRCA1 in vivo and in vitro, BARD1 shares homology with the 2 most conserved regions of BRCA1: the N terminal RING motif and the C terminal BRCT domain. The RING motif is a cysteine rich sequence found in a variety of proteins that regulate cell growth, including the products of tumor suppressor genes and dominant protooncogenes. The BARD1 protein also contains 3 tandem ankyrin repeats. The BARD1/BRCA1 interaction is disrupted by tumorigenic amino acid substitutions in BRCA1, implying that the formation of a stable complex between these proteins may be an essential aspect of BRCA1 tumor suppression. BARD1 may be the target of oncogenic mutations in breast or ovarian cancer. BARD1 also plays a role in mediating apoptotic stress and p53 dependent.


Subunit:
Homo- and heterodimer. Heterodimer


Subcellular Location:
Nucleus.


Similarity:
Contains 4 ANK repeats. 
Contains 2 BRCT domains. 
Contains 1 RING-type zinc finger.


Important Note:
This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.
信息声明:本产品供应信息由仪器网为您整合,供应商为(上海瑞齐生物科技有限公司),内容包括 (乳腺癌易感基因环状结构域蛋白抗体)的品牌、型号、技术参数、详细介绍等;如果您想了解更多关于 (乳腺癌易感基因环状结构域蛋白抗体)的信息,请直接联系供应商,给供应商留言!
供应商产品推荐
    您可能感兴趣的产品